**NM signifies a non meaningful value. A dash signifies the data is not available.

In March 2025, through two transactions SWK monetized its performing royalty portfolio for approximately $51.3 million and anticipates declaring a dividend on the closing of the larger transaction.

On March 17, 2025, ANI Pharmaceuticals, Inc. exercised its buyout option related to the Iluvien royalty, which resulted in a payment of approximately $17.3 million to SWK.

SWK boasts a Value Style Score of B and VGM Score of A, and holds a Zacks Rank #3 (Hold) rating. Shares of Stanley Black & Decker are trading at a forward earnings multiple of 15.7X, as well as a ...